Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myeloma
Crossref DOI link: https://doi.org/10.1007/s10928-016-9469-x
Published Online: 2016-03-18
Published Print: 2016-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gibiansky, Leonid
Passey, Chaitali
Roy, Amit
Bello, Akintunde
Gupta, Manish
Funding for this research was provided by:
Bristol-Myers Squibb
Text and Data Mining valid from 2016-03-18